CompletedNot Applicable

Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias

Brazil46 participantsStarted 2023-01-10

Plain-language summary

This study tested V Eraser, Transdermal radiofrequency versus polidocanol sclerotherapy for the treatment of reticular veins and telangiectasia of the legs

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients willing to sign informed consent * Patients from 18 to 80 years old with CVD classified as CEAP clinical classes C1 to C5, but only telangiectasias and reticular veins not connected to larger varicosities Exclusion Criteria: * Patients with great saphenous or small saphenous vein insufficiency. * Patients with allergies to polidocanol * Patients with contraindications to treat varicose veins

What they're measuring

Photographic analysis

Timeframe: 30 days

Aberdeen AVVQ questionnaire

Timeframe: 30 days

Trial details

NCT IDNCT06962813

SponsorScience Valley Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-02

View on ClinicalTrials.gov More Varicose Veins Leg trials